ORABI, K. Microbial Metabolism of Rofecoxib, A Selective COX-2 Inhibitor. International Journal of Biotechnology for Wellness Industries, [S. l.], v. 1, n. 4, p. 235–240, 2013. DOI: 10.6000/1927-3037.2012.01.04.3. Disponível em: http://lifescienceglobalca.com/index.php/ijbwi/article/view/463. Acesso em: 22 dec. 2024.